Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab in metastatic colorectal cancer
NCT00109070Phase 3Completed
- Sponsor
- Genentech
- Start
- Sep 2000
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of bevacizumab in metastatic colorectal cancer (mCRC), sponsored by Genentech. Started Sep 2000; status: completed.
02
Drugs
bevacizumab
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT00109070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00109070.